Biologics Contract Manufacturing Market By Product Type (Monoclonal Antibodies, Vaccines, Gene Therapy, Cell Therapy and Others), By Indication (Oncology, Autoimmune Diseases, Cardiovascular Diseases, Infectious Diseases and Other), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Table of Content

• 1. Research Methodology and Data Source
  • 1.1. Methodology/Research Approach
  • 1.2. Market Size Estimation
  • 1.3. Market Breakdown and Data Triangulation
  • 1.4. Data Sources
  • 1.5. Secondary Sources
  • 1.6. Primary Sources
• 2. Executive Summary
  • 2.1. Taxonomy
  • 2.2. Global Market Outlook
  • 2.3. Key Facts and Figures
  • 2.4. Major Players in Biologics Contract Manufacturing Market
• 3. Global Market Overview
  • 3.1. Industry Overview
  • 3.2. Segmental Overview
  • 3.3. Regional Overview
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
    • 3.4.4. Trends
  • 3.5. Regulatory Framework
  • 3.6. Opportunity Map Analysis
  • 3.7. Opportunity Orbits
  • 3.8. Market Investment Feasibility Index
  • 3.9. PESTLE Analysis
  • 3.10. PORTER’S Five Force Analysis
  • 3.11. Drivers & Restraints Impact Analysis
  • 3.12. Patient Journey Mapping
  • 3.13. Technological Landscape
  • 3.14. Product Life Cycle Analysis
  • 3.15. Value Chain Analysis
    • 3.15.1. List of Raw Material Suppliers
    • 3.15.2. List of Biologics Contract Manufacturing Manufacturers
    • 3.15.3. List of Dealer/Distributors
    • 3.15.4. List of Potential Customers
  • 3.16. Cost Structure Analysis
  • 3.17. Regional Market Share and BPS Analysis
• 4. Macro-economic Factors
• 5. Impact of Current Geopolitical Scenario
• 6. Global Biologics Contract Manufacturing Market Analysis and Forecast, By Product Type
  • 6.1. Key Findings
  • 6.2. Global Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 6.2.1. Monoclonal Antibodies
    • 6.2.2. Vaccines
    • 6.2.3. Gene Therapy
    • 6.2.4. Cell Therapy
    • 6.2.5. Others
  • 6.3. Global Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
• 7. Global Biologics Contract Manufacturing Market Analysis and Forecast, By Indication
  • 7.1. Key Findings
  • 7.2. Global Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 7.2.1. Oncology
    • 7.2.2. Autoimmune Diseases
    • 7.2.3. Cardiovascular Diseases
    • 7.2.4. Infectious Diseases
    • 7.2.5. Other
• 7.3. Global Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
• 8. Global Biologics Contract Manufacturing Market Analysis and Forecast, By Region
  • 8.1. Key Findings
  • 8.2. Global Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Region, 2020-2035
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Middle East & Africa
    • 8.2.5. Latin America
  • 8.3. Global Biologics Contract Manufacturing Market Attractiveness Analysis, By Region
• 9. North America Biologics Contract Manufacturing Market Analysis and Forecast, 2020-2035
  • 9.1. Key Findings
  • 9.2. North America Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
  • 9.3. North America Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
  • 9.4. North America Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
  • 9.5. North America Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
  • 9.6. North America Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Country, 2020-2035
  • 9.7. North America Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
    • 9.7.1. The US Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 9.7.2. The US Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 9.7.3. Canada Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 9.7.4. Canada Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
• 10. Europe Biologics Contract Manufacturing Market Analysis and Forecast, 2020-2035
  • 10.1. Key Findings
  • 10.2. Europe Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
  • 10.3. Europe Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
  • 10.4. Europe Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
  • 10.5. Europe Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
  • 10.6. Europe Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Country, 2020-2035
  • 10.7. Europe Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
    • 10.7.1. Germany Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 10.7.2. Germany Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 10.7.3. The U.K. Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 10.7.4. The U.K. Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 10.7.5. France Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 10.7.6. France Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 10.7.7. Spain Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 10.7.8. Spain Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 10.7.9. Italy Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 10.7.10. Italy Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 10.7.11. Russia & CIS Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 10.7.12. Russia & CIS Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 10.7.13. Rest of Europe Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 10.7.14. Rest of Europe Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
• 11. Asia Pacific Biologics Contract Manufacturing Market Analysis and Forecast, 2020-2035
  • 11.1. Key Findings
  • 11.2. Asia Pacific Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
  • 11.3. Asia Pacific Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
  • 11.4. Asia Pacific Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
  • 11.5. Asia Pacific Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
  • 11.6. Asia Pacific Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Country, 2020-2035
  • 11.7. Asia Pacific Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
    • 11.7.1. China Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 11.7.2. China Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 11.7.3. India Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 11.7.4. India Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 11.7.5. Japan Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 11.7.6. Japan Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 11.7.7. South Korea Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 11.7.8. South Korea Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 11.7.9. ASEAN Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 11.7.10. ASEAN Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 11.7.11. Australia & New Zealand Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 11.7.12. Australia & New Zealand Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 11.7.13. Rest of Asia Pacific Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 11.7.14. Rest of Asia Pacific Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
• 12. Middle East & Africa Biologics Contract Manufacturing Market Analysis and Forecast, 2020-2035
  • 12.1. Key Findings
  • 12.2. Middle East & Africa Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
  • 12.3. Middle East & Africa Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
  • 12.4. Middle East & Africa Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
  • 12.5. Middle East & Africa Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
  • 12.6. Middle East & Africa Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Country, 2020-2035
  • 12.7. Middle East & Africa Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
    • 12.7.1. GCC Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 12.7.2. GCC Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 12.7.3. South Africa Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 12.7.4. South Africa Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 12.7.5. Rest of Middle East & Africa Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 12.7.6. Rest of Middle East & Africa Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
• 13. Latin America Biologics Contract Manufacturing Market Analysis and Forecast, 2020-2035
  • 13.1. Key Findings
  • 13.2. Latin America Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
  • 13.3. Latin America Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
  • 13.4. Latin America Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
  • 13.5. Latin America Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
  • 13.6. Latin America Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Country, 2020-2035
  • 13.7. Latin America Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
    • 13.7.1. Brazil Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 13.7.2. Brazil Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 13.7.3. Mexico Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 13.7.4. Mexico Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
    • 13.7.5. Rest of Latin America Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Product Type, 2020-2035
    • 13.7.6. Rest of Latin America Biologics Contract Manufacturing Market Size Value (US$ Mn) Forecast, By Indication, 2020-2035
• 14. Competitive Landscape & Company Profiles
  • 14.1. Market Competition Scenario Analysis, By Company
  • 14.2. Competitor Landscape
  • 14.3. Company Share Analysis
  • 14.4. Company Profiles
    • 14.4.1. Thermo Fisher Scientific
      • 14.4.1.1. Company Details
      • 14.4.1.2. Business Overview
      • 14.4.1.3. Product Portfolio
      • 14.4.1.4. Financial Insights
      • 14.4.1.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.1.6. SWOT Analysis
      • 14.4.1.7. Geographic Footprint
    • 14.4.2. Samsung Biologics
      • 14.4.2.1. Company Details
      • 14.4.2.2. Business Overview
      • 14.4.2.3. Product Portfolio
      • 14.4.2.4. Financial Insights
      • 14.4.2.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.2.6. SWOT Analysis
      • 14.4.2.7. Geographic Footprint
    • 14.4.3. Lonza Group
      • 14.4.3.1. Company Details
      • 14.4.3.2. Business Overview
      • 14.4.3.3. Product Portfolio
      • 14.4.3.4. Financial Insights
      • 14.4.3.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.3.6. SWOT Analysis
      • 14.4.3.7. Geographic Footprint
    • 14.4.4. Catalent
      • 14.4.4.1. Company Details
      • 14.4.4.2. Business Overview
      • 14.4.4.3. Product Portfolio
      • 14.4.4.4. Financial Insights
      • 14.4.4.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.4.6. SWOT Analysis
      • 14.4.4.7. Geographic Footprint
    • 14.4.5. Samsung Bioepis
      • 14.4.5.1. Company Details
      • 14.4.5.2. Business Overview
      • 14.4.5.3. Product Portfolio
      • 14.4.5.4. Financial Insights
      • 14.4.5.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.5.6. SWOT Analysis
      • 14.4.5.7. Geographic Footprint
    • 14.4.6. Fujifilm Diosynth Biotechnologies
      • 14.4.6.1. Company Details
      • 14.4.6.2. Business Overview
      • 14.4.6.3. Product Portfolio
      • 14.4.6.4. Financial Insights
      • 14.4.6.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.6.6. SWOT Analysis
      • 14.4.6.7. Geographic Footprint
    • 14.4.7. Wuxi Biologics
      • 14.4.7.1. Company Details
      • 14.4.7.2. Business Overview
      • 14.4.7.3. Product Portfolio
      • 14.4.7.4. Financial Insights
      • 14.4.7.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.7.6. SWOT Analysis
      • 14.4.7.7. Geographic Footprint
    • 14.4.8. BioVectra
      • 14.4.8.1. Company Details
      • 14.4.8.2. Business Overview
      • 14.4.8.3. Product Portfolio
      • 14.4.8.4. Financial Insights
      • 14.4.8.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.8.6. SWOT Analysis
      • 14.4.8.7. Geographic Footprint
    • 14.4.9. Boehringer Ingelheim BioXcellence
      • 14.4.9.1. Company Details
      • 14.4.9.2. Business Overview
      • 14.4.9.3. Product Portfolio
      • 14.4.9.4. Financial Insights
      • 14.4.9.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.9.6. SWOT Analysis
      • 14.4.9.7. Geographic Footprint
    • 14.4.10. AGC Biologics
      • 14.4.10.1. Company Details
      • 14.4.10.2. Business Overview
      • 14.4.10.3. Product Portfolio
      • 14.4.10.4. Financial Insights
      • 14.4.10.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 14.4.10.6. SWOT Analysis
      • 14.4.10.7. Geographic Footprint

List of Tables

• Table 1: Global Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 2: Global Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 3: Global Biologics Contract Manufacturing Market Value (US$ Mn), By Region, 2020-2035
• Table 4: North America Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 5: North America Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 6: North America Biologics Contract Manufacturing Market Value (US$ Mn), By Country, 2020-2035
• Table 7: The US Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 8: The US Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 9: Canada Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 10: Canada Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 11: Europe Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 12: Europe Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 13: Europe Biologics Contract Manufacturing Market Value (US$ Mn), By Country, 2020-2035
• Table 14: Germany Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 15: Germany Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 16: The U.K. Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 17: The U.K. Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 18: France Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 19: France Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 20: Spain Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 21: Spain Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 22: Italy Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 23: Italy Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 24: Russia & CIS Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 25: Russia & CIS Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 26: Rest of Europe Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 27: Rest of Europe Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 28: Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 29: Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 30: Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn), By Country, 2020-2035
• Table 31: China Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 32: China Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 33: India Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 34: India Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 35: Japan Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 36: Japan Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 37: South Korea Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 38: South Korea Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 39: ASEAN Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 40: ASEAN Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 41: Australia & New Zealand Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 42: Australia & New Zealand Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 43: Rest of Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 44: Rest of Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 45: Middle East & Africa Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 46: Middle East & Africa Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 47: Middle East & Africa Biologics Contract Manufacturing Market Value (US$ Mn), By Country, 2020-2035
• Table 48: GCC Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 49: GCC Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 50: South Africa Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 51: South Africa Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 52: Rest of Middle East & Africa Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 53: Rest of Middle East & Africa Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 54: Latin America Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 55: Latin America Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 56: Latin America Biologics Contract Manufacturing Market Value (US$ Mn), By Country, 2020-2035
• Table 57: Brazil Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 58: Brazil Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 59: Mexico Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 60: Mexico Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035
• Table 61: Rest of Latin America Biologics Contract Manufacturing Market Value (US$ Mn), By Product Type, 2020-2035
• Table 62: Rest of Latin America Biologics Contract Manufacturing Market Value (US$ Mn), By Indication, 2020-2035

List of Figures

• Figure 1: Global Biologics Contract Manufacturing Market Value (US$ Mn), 2020-2035
• Figure 2: Global Biologics Contract Manufacturing Market Value Share (%) Analysis, By Product Type, 2025 & 2035
• Figure 3: Global Biologics Contract Manufacturing Market Value Share (%) Analysis, By Indication, 2025 & 2035
• Figure 4: Global Biologics Contract Manufacturing Market Value Share (%) Analysis, By Region, 2025 & 2035
• Figure 5: Global Biologics Contract Manufacturing Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
• Figure 6: Global Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
• Figure 7: Global Biologics Contract Manufacturing Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
• Figure 8: Global Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
• Figure 9: Global Biologics Contract Manufacturing Market Value Share (%) Analysis, By Region, 2020, 2025 and 2035
• Figure 10: Global Biologics Contract Manufacturing Market Attractiveness Analysis, By Region
• Figure 11: North America Biologics Contract Manufacturing Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
• Figure 12: North America Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
• Figure 13: North America Biologics Contract Manufacturing Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
• Figure 14: North America Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
• Figure 15: North America Biologics Contract Manufacturing Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 16: North America Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
• Figure 17: Europe Biologics Contract Manufacturing Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
• Figure 18: Europe Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
• Figure 19: Europe Biologics Contract Manufacturing Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
• Figure 20: Europe Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
• Figure 21: Europe Biologics Contract Manufacturing Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 22: Europe Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
• Figure 23: Asia Pacific Biologics Contract Manufacturing Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
• Figure 24: Asia Pacific Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
• Figure 25: Asia Pacific Biologics Contract Manufacturing Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
• Figure 26: Asia Pacific Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
• Figure 27: Asia Pacific Biologics Contract Manufacturing Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 28: Asia Pacific Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
• Figure 29: Middle East & Africa Biologics Contract Manufacturing Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
• Figure 30: Middle East & Africa Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
• Figure 31: Middle East & Africa Biologics Contract Manufacturing Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
• Figure 32: Middle East & Africa Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
• Figure 33: Middle East & Africa Biologics Contract Manufacturing Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 34: Middle East & Africa Biologics Contract Manufacturing Market Attractiveness Analysis, By Country
• Figure 35: Latin America Biologics Contract Manufacturing Market Value Share (%) Analysis, By Product Type, 2020, 2025 and 2035
• Figure 36: Latin America Biologics Contract Manufacturing Market Attractiveness Analysis, By Product Type
• Figure 37: Latin America Biologics Contract Manufacturing Market Value Share (%) Analysis, By Indication, 2020, 2025 and 2035
• Figure 38: Latin America Biologics Contract Manufacturing Market Attractiveness Analysis, By Indication
• Figure 39: Latin America Biologics Contract Manufacturing Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 40: Latin America Biologics Contract Manufacturing Market Attractiveness Analysis, By Country